1. Angell, M. (2005). The truth about the drug companies: How they deceive us and what to do about it. New York: Random House.
2. APHA (American Public Health Association). (2003). Supporting legislation for independent post-marketing phase IV Comparative evaluation of pharmaceuticals. Washington, DC: APHA.
3. Beder, S. (2000). Global spin (rev ed.). White River Junction, VT: Chelsea Green.
4. Bekelman, J., Lee, Y., & Gross, C. (2003). Scope and impact of financial conflicts of interest in biomedical research. Journal of the American Medical Association, 289, 454–465.
5. Borgert, C. (2007). Conflict of interest or contravention of science. Regulatory Toxicology and Pharmacology, 48, 4–5.